Pulse oximetry: A viable screening tool for infants with suspected congenital heart disease

Pulse oximetry, a non-invasive procedure that measures the amount of oxygen in the bloodstream, can be used as a screening tool to detect critical congenital heart disease (CCHD) in infants, and is more readily available than echocardiography, the current gold standard for CCHD diagnosis, according to a new research abstract presented Friday, Oct. 14, at the American Academy of Pediatrics (AAP) National Conference and Exhibition (NCE) in Boston.

In September, the U.S. Department of Health and Human Services added pulse oximetry to the list of core screening standards; however, no research has been conducted that looks at the availability of these devices, or their frequency of use.

Researchers surveyed nurse managers and administrators at 88 of the 99 Wisconsin hospitals which routinely deliver newborns. All responding hospitals had pulse oximetry available in the nursery, of which 28.4 percent (representing one-third of all newborns in Wisconsin) routinely used this device to screen for CCHD. In contrast, same-day echocardiography was available at only 37.5 percent of the responding hospitals. More than 26 percent of births occurred in a facility where same-day neonatal echocardiography was not available, with the average distance to a higher-level care facility of choice being 53.1 miles.

"There is a large body of literature on pulse oximetry as a for critical congenital heart disease from Europe; however, there is very little population-based information on this type of screening in the health care systems of the United States," said lead study author Daniel J. Beissel, MD.

"Although the use of pulse oximetry is a relatively new tool in screening for critical , its use is expanding rapidly," said Dr. Beissel. "The implementation of is likely to expand further as more and more states pass legislation requiring this type of screening in all ."

Provided by American Academy of Pediatrics

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Newest screen for newborns will indicate heart problems

Aug 22, 2011

About 1 in every 120 babies are born with congenital heart disease (CHD), of which about 25 percent is critical, requiring special care early in life. CHD is responsible for more deaths in the first year of life than any ...

Simple screening test identifies heart defects in newborns

Aug 05, 2011

A simple test to measure blood oxygen in newborns has been shown to identify babies with life-threatening congenital heart defects, a major cause of infant mortality in the developed world, according to researchers from the ...

Pulse oximetry training video published in NEJM

Apr 20, 2011

A pulse oximetry training video produced by Rafael Ortega, MD, the vice-chair of academic affairs for the department of anesthesiology at Boston Medical Center (BMC) and professor of anesthesiology at Boston University School ...

Recommended for you

Correction of cardiovascular symptoms of MPS I in animal model

50 minutes ago

REGENXBIO Inc. today announced that gene transfer mediated by REGENXBIO's NAV AAV8 vectors resulted in sustained serum α-L-iduronidase (IDUA) expression, as well as correction of systemic features of MPS I, or Hurler syndrome, ...

Researchers explain 38-year-old mystery of the heart

14 hours ago

In a new study published in Proceedings of the National Academy of Sciences, researchers at the University of Alberta's Faculty of Medicine & Dentistry have explained how the function of a key protein in the ...

User comments